Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and Therapeutic Drug Monitoring in Chinese Patients With Invasive Pulmonary Infection

NCT04004078 is registered in ClinicalTrials.gov with People's Hospital of Zhengzhou University as lead sponsor.

NCT NCT04004078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and Therapeutic Drug Monitoring in Chinese Patients With Invasive Pulmonary Infection
Lead sponsor
People's Hospital of Zhengzhou University
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
May 1, 2021
Enrollment
314 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive fungal infection